Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
H. Lee Moffitt Cancer Center and Research Institute
Immatics US, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Northwestern University
Cancer Research UK